Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Onconetix (ONCO) Revenue (2023 - 2025)

Historic Revenue for Onconetix (ONCO) over the last 3 years, with Q3 2025 value amounting to $303651.0.

  • Onconetix's Revenue fell 2536.7% to $303651.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 million, marking a year-over-year decrease of 2462.77%. This contributed to the annual value of $2.5 million for FY2024, which is 421731.12% up from last year.
  • According to the latest figures from Q3 2025, Onconetix's Revenue is $303651.0, which was down 2536.7% from $106494.0 recorded in Q2 2025.
  • In the past 5 years, Onconetix's Revenue ranged from a high of $711976.0 in Q4 2024 and a low of -$269097.0 during Q3 2023
  • Its 3-year average for Revenue is $236426.6, with a median of $205072.5 in 2025.
  • In the last 5 years, Onconetix's Revenue surged by 47764.2% in 2024 and then crashed by 8549.04% in 2025.
  • Onconetix's Revenue (Quarter) stood at -$188532.0 in 2023, then soared by 477.64% to $711976.0 in 2024, then plummeted by 57.35% to $303651.0 in 2025.
  • Its Revenue stands at $303651.0 for Q3 2025, versus $106494.0 for Q2 2025 and $101630.0 for Q1 2025.